Examining the Potential Price Growth of Biolife Solutions Inc (BLFS)

In a filing, Biolife Solutions Inc revealed its Chief Human Resources Officer Aebersold Sarah unloaded Company’s shares for reported $15806.0 on Jun 16 ’25. In the deal valued at $22.23 per share,711 shares were sold. As a result of this transaction, Aebersold Sarah now holds 78,721 shares worth roughly $1.68 million.

Then, SARAH AEBERSOLD bought 711 shares, generating $15,663 in total proceeds.

Before that, Casdin Partners Master Fund, L sold 1,000,000 shares. Biolife Solutions Inc shares valued at $23,800,000 were divested by the 10% Owner at a price of $23.80 per share. As a result of the transaction, Casdin Partners Master Fund, L now holds 7,707,165 shares, worth roughly $164.63 million.

H.C. Wainwright initiated its Biolife Solutions Inc [BLFS] rating to a Buy in a research note published on September 30, 2024; the price target was $29. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Craig Hallum began covering BLFS with “Buy” recommendation on July 11, 2023. Oppenheimer revised its rating on April 25, 2022. It rated BLFS as “an Outperform” which previously was an “a Perform”.

Price Performance Review of BLFS

On Monday, Biolife Solutions Inc [NASDAQ:BLFS] saw its stock jump 0.66%% to $21.36. Over the last five days, the stock has lost -3.04%. Biolife Solutions Inc shares have risen nearly 7.01% since the year began. Nevertheless, the stocks have fallen -17.72% over the past one year. While a 52-week high of $29.55 was reached on 01/30/25, a 52-week low of $18.70 was recorded on 04/09/25.

Levels Of Support And Resistance For BLFS Stock

The 24-hour chart illustrates a support level at 20.70, which if violated will result in even more drops to 20.04. On the upside, there is a resistance level at 21.82. A further resistance level may holdings at 22.28.

How much short interest is there in Biolife Solutions Inc?

A steep rise in short interest was recorded in Biolife Solutions Inc stocks on 2025-05-30, growing by 0.74 million shares to a total of 4.68 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 3.94 million shares. There was a rise of 15.81%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on October 19, 2021 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $61 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.